0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editorial |

Hormone Replacement Therapy and Heart Disease Prevention:  Experimentation Trumps Observation

Diana B. Petitti, MD
JAMA. 1998;280(7):650-652. doi:10.1001/jama.280.7.650.
Text Size: A A A
Published online

Extract

Three different meta-analyses13 have concluded that estrogen replacement therapy (ERT) decreases the risk of coronary heart disease (CHD) by 35% to 50%. The predicted increase in life expectancy in hormone users, based on estimates of the risk of CHD in users of ERT derived from observational studies, is 2 to 3 years.2,4 The effects of ERT and combined estrogen-progestin replacement therapy (HRT) on lipids and fibrinolysis are strongly beneficial for both ERT and HRT.5 This has led to extrapolation of the results of observational studies of ERT to HRT and to promotion of the use of both ERT and HRT in women with CHD.2,6 The results of the Heart and Estrogen/progestin Replacement Study (HERS), which are reported by Hulley et al in this issue of JAMA,7 add critically important data on the effects of HRT. In this randomized controlled trial of 2763 postmenopausal women with established coronary disease, treatment with estrogen plus progestin did not reduce the rate of CHD events (eg, nonfatal myocardial infarction or CHD-related death). These findings are a sobering reminder of the limitations of observational research, the incompleteness of current understanding of the mechanisms of vascular disease, and the dangers of extrapolation.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 94

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
CME Related by Topic
PubMed Articles
Jobs
brightcove.createExperiences();